–
Статьи в журналах
-
- 2016 MAESTRO: A randomized, double-blind phase III study of evofosfamide (Evo) in combination with gemcitabine (Gem) in previously untreated patients (pts) with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma (PDAC)
- Van Cutsem Eric, Lenz Heinz-Josef, Furuse Junji, Tabernero Josep, Heinemann Volker, Ioka Tatsuya, Bazin Igor, Ueno Makoto, Csoszi Tibor, Wasan Harpreet, Melichar Bohuslav, Karasek Petr, Macarulla Teresa Mercade, Guillen Carmen, Kalinka-Warzocha Ewa, Horvath Zsolt, Prenen Hans, Schlichting Michael, Ibrahim Ayman, Bendell Johanna C.
- в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 34, № 15 DOI
-
- 2016 The prostate cancer registry: Patient characteristics, treatments and preliminary outcomes from a large observational study of metastatic castration-resistant prostate cancer (mCRPC)
- Chowdhury S., Birtle A.J., Bjartell A., Costa L.A., Feyerabend S., Galli L., Kalinka-Warzocha E., Kramer G., Maroto Rey J.P., Lumen N., Matveev V.B., Paiss T., Spaeth D., Antoni L., Klumper E., Wapenaar R., Lee E.
- в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 27, № 6, с. 746P-746 DOI